Chromai (Beijing) Technology Co., Ltd.

Mission Vision

Mission

Make analytical testing more efficient, precise and easy to use.
Vision

Become a Chinese technology company advancing global and human health & safety.
Core Values

Customer Success, Lean Innovation, Integrity & Accountability, Unity & Progress.

History

2019

September 9: Chromai officially founded.
2020

In February, the company secured ten-million-yuan level Angel Round financing.It launched its first product for the general field — the Leaps series, earning numerous honors for domestic liquid chromatography.
2021

In August, the company secured tens of millions of yuan in Pre-A round financing.It launched its first medical product—the Voyager series, making it one of the few domestic enterprises to develop ultra-high performance liquid chromatography (UHPLC) products for the clinical medical field.
2022

Suzhou Phase I Production Base Launched and Put into OperationAwarded the qualification of "National High-Tech Enterprise"The Voyager product obtained the first Class II Medical Device Registration Certificate for domestic products
2023

Completed nearly 100 million yuan Series A financing in June.

Launched the Frontier series and won the BCEIA Gold Award.

Initiated the LC-MS strategy to build China’s leading clinical scenario solutions.
2024

Recognized as a Specialized, Sophisticated, Unique and New Small and Medium-sized Enterprise in Beijing.

Chromai won the Investment Potential Enterprise Award in the Scientific Instrument Industry at ACCSI 2024.
2025

Secured tens of millions of yuan in Series A+ financing in August.

The ultra-high-pressure binary pump and quaternary pump integrate a number of breakthrough technologies, making us the world’s second manufacturer of ultra-high performance liquid chromatography (UHPLC) with a pressure resistance exceeding 22,040 Psi (1,520 Bar).

Secured tens of millions of yuan in strategic financing in December.